ICM
CELU icon

Ionic Capital Management’s Celularity CELU Stock Holding History

Ionic Capital Management’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,250
Closed -$89K – 382
2021
Q3 		$89K Buy
+1,250
New +$101K 0.01% 307

Other funds holding CELU

SIC
Starr International Company Zug, Switzerland $19.9M AUM 39.69% 1-Year Est. Return
CVSC
C.V. Starr & Co New York $192M AUM 35.69% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
LDFO
Louis-Dreyfus Family Office Wilton, Connecticut $64.7M AUM 21.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BRF
B. Riley Financial Los Angeles, California $456M AUM 896.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Ionic Capital Management's CELU Position: Q1 2022 in Review

Ionic Capital Management sold out of Celularity (CELU) in Q1 2022, closing a stake of 696 shares — an estimated $41.7K sold.

Ionic Capital Management first reported a position in CELU in Q4 2021 and held it in 1 quarter. The position peaked at $36K in Q4 2021. 38 funds tracked by Wall St. Rank hold CELU as of Q1 2022.

  • Ionic Capital Management reported no remaining Celularity position as of Q1 2022 after selling out during the quarter.
  • Ionic Capital Management sold 696 Celularity shares in Q1 2022, an estimated $41.7K.
  • Ionic Capital Management first reported a position in Celularity in Q4 2021 and held it in 1 quarter.
  • Ionic Capital Management's Celularity position peaked at $36K in Q4 2021.
  • 38 funds tracked by Wall St. Rank held Celularity as of Q1 2022.

Based on Ionic Capital Management's 13F filing for Q1 2022, filed 16 May 2022.